344 - Pancreatic cancer proliferation is induced by GLI2-Col1 signaling in fibroblasts in the tumor microenvironment
Wednesday, November 2, 2022
6:00 PM – 7:00 PM ET
Location: Exhibit Hall DE CC
Abstract/Description:
First Author: Madeline Ross, n/a, St. Catherine University Second Author: Renzo Vera, PhD, Mayo Clinic Schulze Center for Novel Therapeutics Third Author: Maite Fernandez-Barrena, PhD, Mayo Clinic Schulze Center for Novel Therapeutics Fourth Author: Murat Toruner, MD, FESBGH, Mayo Clinic Schulze Center for Novel Therapeutics Fifth Author: Ezequiel Tolosa, PhD, Mayo Clinic Schulze Center for Novel Therapeutics Sixth Author: Luciana Almada, PhD, Mayo Clinic Schulze Center for Novel Therapeutics Seventh Author: Rolf Brekken, PhD, UT Southwestern Eighth Author: Martin Fernandez-Zapico, MD, Mayo Clinic Schulze Center for Novel Therapeutics
First Author(s)
Madeline D. Ross (she/they)
Undergraduate Student Research Fellow St. Catherine University St. Paul, Minnesota, United States
